HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antitampering bill

This article was originally published in The Rose Sheet

Executive Summary

House legislation to prohibit alteration of product identification codes amended in Judiciary/Courts and Intellectual Property Subcommittee with language similar to Senate version. Like its partner bill, HR 2100 now allows products to be repackaged, addressing a concern from wholesalers interested in discounting prices. In addition, the substitute language allows lawful diversion while prohibiting flea market sales. The Senate version, S 2105, was introduced Feb. 24 (1"The Rose Sheet" March 6, p. 4). The substitute bill, introduced by HR 2100 author Rep. Bob Goodlatte (R-Va.), passed the subcommittee 6-3 on March 23

You may also be interested in...



Senate Antitampering Bill Addresses Price Discounting Concerns - Leahy

Senate legislation language prohibiting tampering with product identification codes on consumer products contains "significant improvements" over a version introduced in the House, co-sponsor Sen. Patrick Leahy (D-Vt.) maintained on the Senate floor Feb. 24.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
UsernamePublicRestriction

Register

RS007831

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel